surmount study tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Discover evidence-based steps to get back on schedule, when to take your next injection, and how to prevent gaps in your weight loss therapy

20 Grams of Protein: High-quality sources that deliver a complete amino acid profile

Initial Consultation to confirm eligibility $150 Request AppointmentIncludes - Medication is $400/Month - Includes Monthly visits with provider - One Semaglutide Injection/WeekDedicated To Patients Seeking Weight Loss Management

Semaglutide passes into breast milk in animal studies, making breastfeeding generally incompatible with GLP-1 therapy

Medical weight loss in Cleveland, OH with Semaglutide & Tirzepatide

Wipe both vial tops (Tirzepatide and BAC Water) with alcohol pads